Loading...
Generate Biomedicines (GENB, $15.87) was one of top quarterly gainers, jumping +3 to $15.87 per share. A.I.dvisor analyzed 593 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.